Letter in reply to the letter to the editor of Geerts N and Schanhorst V with the title “Roche Troponin T hs-STAT meets all expert opinion analytical laboratory practice recommendations for the use of the differential diagnosis of acute coronary syndrome”

Articles in the same Issue

1. Frontmatter
2. Editorials
3. Perspectives in developments of mass spectrometry for improving diagnosis and monitoring of multiple myeloma and other plasma cell disorders
4. Cytokine “storm”, cytokine “breeze”, or both in COVID-19?
5. Review
6. Clinical relevance of biological variation of cardiac troponins
7. General Clinical Chemistry and Laboratory Medicine
8. Development of novel methods for non-canonical myeloma protein analysis with an innovative adaptation of immunofixation electrophoresis, native top-down mass spectrometry, and middle-down de novo sequencing
9. Falsely markedly elevated 25-hydroxyvitamin D in patients with monoclonal gammopathies
10. Development of a pregnancy-specific reference material for thyroid biomarkers, vitamin D, and nutritional trace elements in serum
11. Applying the concept of uncertainty to the sFlt-1/PlGF cut-offs for diagnosis and prognosis of preeclampsia
12. Reducing sample rejection in Durban, South Africa
13. Quality benchmarking of smartphone laboratory medicine applications: comparison of laboratory medicine specialists’ and non-laboratory medicine professionals’ evaluation
14. Urine soluble CD163 (sCD163) as biomarker in glomerulonephritis: stability, reference interval and diagnostic performance
15. Measurement of urine albumin by liquid chromatography-isotope dilution tandem mass spectrometry and its application to value assignment of external quality assessment samples and certification of reference materials
16. Choice of faecal immunochemical test matters: comparison of OC-Sensor and HM-JACKarc, in the assessment of patients at high risk of colorectal cancer
17. Reference Values and Biological Variations
18. Reference values of trace elements in blood and/or plasma in adults living in Belgium
19. Cancer Diagnostics
20. Clinical performance of calcitonin and procalcitonin Elecsys^® immunoassays in patients with medullary thyroid carcinoma
21. Cardiovascular Diseases
22. Analytical assessment of ortho clinical diagnostics high-sensitivity cardiac troponin I assay
23. Evaluation of the 0 h/1 h high-sensitivity cardiac troponin T algorithm in diagnosis of non-ST-segment elevation myocardial infarction (NSTEMI) in Han population
24. Diabetes
25. Are hemoglobin A_1c point-of-care analyzers fit for purpose? The story continues
26. Infectious Diseases
27. Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection
28. Hemocytometric characteristics of COVID-19 patients with and without cytokine storm syndrome on the sysmex XN-10 hematology analyzer
29. Letters to the Editor
30. Letter in reply to the letter to the editor of Geerts N and Schanhorst V with the title “Roche Troponin T hs-STAT meets all expert opinion analytical laboratory practice recommendations for the use of the differential diagnosis of acute coronary syndrome”
31. Improving measurement uncertainty of plasma electrolytes: a complex but not impossible task
32. Truncation limits of patient-based real-time quality control: a new model derived from between-subject biological variations
33. Plasma xanthine oxidoreductase activity change over 12 months independently associated with change in serum uric acid level: MedCity21 health examination registry
34. Exogenous triglycerides interfere with a point of care CRP assay: a pre-analytical caveat
35. Monoclonal components in alpha-2 region should not be neglected in capillary electrophoresis
36. Do not measure an extra high value monoclonal IgM by immunoturbidity: a case report
37. Reference values for plasma neurofilament light chain (NfL) in healthy Chinese
38. Diagnosis of vitamin B12 deficiency: combined indicator of B12-status should be interpreted with caution in the case of renal impairment
39. Could the UKNEQAS program “Manual Differential Blood Count” be performed by the use of an automated digital morphology analyzer (Sysmex DI-60)? A feasibility study
40. Low-dose oral methotrexate-induced crystalluria